fanasil, pyrimethamine drug combination has been researched along with prednisolone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukutomi, Y; Goto, H; Hara, T; Moriwaki, H; Murakami, N; Tajika, M; Tsurumi, H; Yoshimura, K | 1 |
| Hashimoto, H; Iida, N; Maeda, M; Mori, K; Nawata, M; Sekigawa, I; Seta, N; Shimizu, T; Wada, R | 1 |
2 other study(ies) available for fanasil, pyrimethamine drug combination and prednisolone
| Article | Year |
|---|---|
[Non-Hodgkin's lymphoma with Toxoplasma encephalitis].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Antiprotozoal Agents; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Combinations; Encephalitis; Humans; Lymphoma, T-Cell; Male; Middle Aged; Prednisolone; Pyrimethamine; Remission Induction; Sulfadoxine; Toxoplasmosis, Cerebral; Vincristine | 1999 |
A possible novel mechanism of opportunistic infection in systemic lupus erythematosus, based on a case of toxoplasmic encephalopathy.
Topics: Adult; Animals; Anti-Infective Agents; Antibodies, Protozoan; Cerebral Cortex; Drug Combinations; Female; Humans; Immunocompromised Host; Lupus Erythematosus, Systemic; Opportunistic Infections; Prednisolone; Pyrimethamine; Sulfadoxine; Sulfamonomethoxine; Tomography, X-Ray Computed; Toxoplasma; Toxoplasmosis, Cerebral; Treatment Outcome | 2002 |